Backlinks
| Referring page | DR | Ref. domains | Linked domains | Anchor and target URL |
|---|---|---|---|---|
|
Johnson & Johnson Releases Report on Surgeon Burnout as More than 40% Surveye...
https://www.jnj.com/media-center/press-releases/johnson-johnson-releases-report-on-surgeon-burnout-as-more-than-40-surveyed-consider-leaving-the-profession
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Johnson & Johnson files for U.S. FDA approval of DARZALEX FASPRO®-based quadr...
https://www.jnj.com/media-center/press-releases/johnson-johnson-files-for-u-s-fda-approval-of-darzalex-faspro-based-quadruplet-regimen-for-newly-diagnosed-multiple-myeloma-patients-for-whom-transplant-is-not-planned
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Johnson & Johnson Celebrates Innovation in Regulated RNA and Protein Degradat...
https://www.jnj.com/media-center/press-releases/johnson-johnson-celebrates-innovation-in-regulated-rna-and-protein-degradation-with-2024-dr-paul-janssen-award-for-biomedical-research
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Janssen to Unveil New Hepatitis B and C Data at The International Liver Congr...
https://www.jnj.com/media-center/press-releases/janssen-to-unveil-new-hepatitis-b-and-c-data-at-the-international-liver-congress-2016-of-the-european-association-for-the-study-of-the-liver-easl
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Season 10 American Idol Finalist and Musician Casey Abrams Releases New Song ...
https://www.jnj.com/media-center/press-releases/season-10-american-idol-finalist-and-musician-casey-abrams-releases-new-song-devoted-to-raising-awareness-about-inflammatory-bowel-disease
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
J&J Impact Ventures | Homepage
https://www.jnj.com/impact-ventures?utm_source=chatgpt.com
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Global health equity
jnj.com
|
80 | 1,350 | 880 |
Advocating for, elevating, and empowering nurses
https://nursing.jnj.com/
DOFOLLOW
|
|
First Regimen Combining Long Acting Injectable Antiretrovirals; 32-Week LATTE...
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
U.S. FDA approves SIMPONI® (golimumab) for the treatment of pediatric ulcerat...
https://www.jnj.com/media-center/press-releases/u-s-fda-approves-simponi-golimumab-for-the-treatment-of-pediatric-ulcerative-colitis
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Alex Gorsky Shares How the World Cup Helps Unite Us
https://www.jnj.com/latest-news/alex-gorsky-shares-how-the-world-cup-helps-unite-us
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Biosense Webster Announces Launch of the CARTO® 3 MEM Base Version
https://www.jnj.com/media-center/press-releases/biosense-webster-announces-launch-of-the-carto-3-mem-base-version
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Johnson & Johnson Updates U.S. COVID-19 Vaccine Fact Sheet
https://www.jnj.com/media-center/press-releases/johnson-johnson-updates-u-s-covid-19-vaccine-fact-sheet
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Why Johnson & Johnson Added Unique Device Identifiers (UDIs)
https://www.jnj.com/innovation/inside-the-decade-long-effort-to-add-digital-tags-to-thousands-of-johnson-johnson-medtech-products
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Website Resources – Nursing Education Department
https://www.palomar.edu/nursing/professional-resources
palomar.edu
|
73 | 94 | 364 |
Discover Nursing
https://nursing.jnj.com/home
DOFOLLOW
|
|
Recognizing Diabetes Alert Day: One Mother's Personal and Professional Journey
https://www.jnj.com/our-company/recognizing-diabetes-alert-day-one-mothers-personal-and-professional-journey
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Scholarships | Financial Aid | Norfolk State University - Norfolk State Unive...
https://www.nsu.edu/Admissions-Aid/Apply-to-NSU/Tuition-and-Financial-Aid/Financial-Aid/Types-of-Aid/Scholarships
nsu.edu
|
71 | 109 | 90 |
Discover Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Johnson & Johnson Reports Q3 2021 Results
https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q3-2021-results
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Impact in Asia: How Johnson & Johnson is helping to create healthier societie...
https://www.jnj.com/health-and-wellness/impact-in-asia-how-johnson-johnson-is-helping-to-create-healthier-societies-one-country-at-a-time
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Johnson & Johnson and Global Partners Announce Results from Phase 2b Imbokodo...
https://www.jnj.com/media-center/press-releases/johnson-johnson-and-global-partners-announce-results-from-phase-2b-imbokodo-hiv-vaccine-clinical-trial-in-young-women-in-sub-saharan-africa
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Johnson & Johnson Completes Acquisition Of Aragon Pharmaceuticals, Inc.
https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-aragon-pharmaceuticals-inc
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
New Results From Second Phase 3 Study Show Significant Efficacy of Guselkumab...
https://www.jnj.com/media-center/press-releases/new-results-from-second-phase-3-study-show-significant-efficacy-of-guselkumab-and-superiority-versus-humira-in-treatment-of-moderate-to-severe-plaque-psoriasis
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Janssen and Global Partners to Discontinue Phase 3 Mosaico HIV Vaccine Clinic...
https://www.jnj.com/media-center/press-releases/janssen-and-global-partners-to-discontinue-phase-3-mosaico-hiv-vaccine-clinical-trial
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Janssen and Global Partners to Discontinue Phase 3 Mosaico HIV Vaccine Clinic...
https://www.jnj.com/media-center/press-releases/janssen-and-global-partners-to-discontinue-phase-3-mosaico-hiv-vaccine-clinical-trial
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Transforming Health Care Through Innovative Nurse-Led Care Delivery Solutions...
https://www.ihi.org/library/tools/transforming-health-care-through-innovative-nurse-led-care-delivery-solutions
ihi.org
|
78 | 561 | 339 |
Actionable Solutions to Improve the Nursing Experience and Patient Care
https://nursing.jnj.com/nursing-news-events/nurses-leading-innovation/actionable-solutions-to-improve-the-nursing-experience-and-patient-care
DOFOLLOW
|
|
TECVAYLI® monotherapy demonstrates superior progression-free and overall surv...
https://www.jnj.com/media-center/press-releases/tecvayli-monotherapy-demonstrates-superior-progression-free-and-overall-survival-versus-standard-of-care-as-early-as-first-relapse-in-patients-with-multiple-myeloma-predominantly-refractory-to-anti-cd38-therapy-and-lenalidomide
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
U.S. FDA Approves AKEEGA™ (Niraparib and Abiraterone Acetate), the First-And-...
https://www.jnj.com/media-center/press-releases/u-s-fda-approves-akeega-niraparib-and-abiraterone-acetate-the-first-and-only-dual-action-tablet-for-the-treatment-of-patients-with-brca-positive-metastatic-castration-resistant-prostate-cancer
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
SAPPHIRE Worldwide Study Data Presented at TCT 2012 Study demonstrates benefi...
https://www.jnj.com/media-center/press-releases/sapphire-worldwide-study-data-presented-at-tct-2012-study-demonstrates-benefit-of-carotid-artery-stenting-in-symptomatic-and-asymptomatic-patients-at-high-risk-of-surgery
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Medical technology press releases | Johnson & Johnson
https://www.jnj.com/media-center/press-releases/medical-technologies
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
RYBREVANT® (amivantamab-vmjw) data at ELCC advance Johnson & Johnson’s ambiti...
https://www.jnj.com/media-center/press-releases/rybrevant-amivantamab-vmjw-data-at-elcc-advance-johnson-johnsons-ambition-to-transform-the-standard-of-care-for-patients-with-egfr-mutated-non-small-cell-lung-cancer
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Dr. Paul Stoffels Discusses the Global Mental Health Epidemic During WEF
https://www.jnj.com/latest-news/paul-stoffels-discusses-global-mental-health-epidemic-world-economic-forum
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Janssen Announces New Data Supporting Safety and Efficacy of RYBREVANT® and L...
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Master's in Nursing Informatics (MSN) | Graduate Programs | Commonwealth Univ...
https://www.commonwealthu.edu/academics/programs/nursing-informatics-msn
commonwealthu.edu
|
69 | 41 | 188 |
Johnson and Johnson
https://nursing.jnj.com/scholarships
DOFOLLOW
|
|
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results
https://www.jnj.com/media-center/press-releases/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results-2024
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
New Long-Term Data Show INVOKANA® (canagliflozin) Lowers Blood Glucose in Old...
https://www.jnj.com/media-center/press-releases/new-long-term-data-show-invokana-canagliflozin-lowers-blood-glucose-in-older-patients-with-type-2-diabetes-inadequately-controlled-on-other-therapies
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
What It’s Like to Undergo Gender Affirmation Surgery
https://www.jnj.com/caring-and-giving/what-its-like-to-undergo-gender-affirmation-surgery
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI® plu...
https://www.jnj.com/media-center/press-releases/unprecedented-results-from-the-phase-3-majestec-3-study-support-tecvayli-plus-darzalex-faspro-as-a-potential-standard-of-care-as-early-as-second-line-for-patients-with-relapsed-refractory-multiple-myeloma?utm_source=ts2.tech
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Economist Intelligence Unit Report Calls for Urgent Global Action to Combat t...
https://www.jnj.com/media-center/press-releases/economist-intelligence-unit-report-calls-for-urgent-global-action-to-combat-the-growing-tuberculosis-pandemic
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
The New England Journal of Medicine Publishes Efficacy Data for ZYTIGA® Plus ...
https://www.jnj.com/media-center/press-releases/the-new-england-journal-of-medicine-publishes-efficacy-data-for-zytiga-plus-prednisone-in-metastatic-castration-resistant-prostate-cancer-in-patients-who-have-not-received-chemotherapy
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Johnson & Johnson Consumer Health announces discontinuation of talc-based Joh...
https://www.jnj.com/our-company/johnson-johnson-consumer-health-announces-discontinuation-of-talc-based-johnsons-baby-powder-in-u-s-and-canada
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Johnson & Johnson Consumer Health announces discontinuation of talc-based Joh...
https://www.jnj.com/our-company/johnson-johnson-consumer-health-announces-discontinuation-of-talc-based-johnsons-baby-powder-in-u-s-and-canada
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Janssen Presents Updated Data Demonstrating Improved Outcomes from the Use of...
https://www.jnj.com/media-center/press-releases/janssen-presents-updated-data-demonstrating-improved-outcomes-from-the-use-of-niraparib-in-combination-with-abiraterone-acetate-plus-prednisone-as-a-first-line-therapy-in-patients-with-brca-positive-metastatic-castration-resistant-prostate-cancer
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
New TREMFYA® (guselkumab) Post-Hoc Analysis Reveals Early Efficacy Predicted ...
https://www.jnj.com/media-center/press-releases/new-tremfya-guselkumab-post-hoc-analysis-reveals-early-efficacy-predicted-longer-term-efficacy-and-sustained-achievement-among-a-diverse-active-psoriatic-arthritis-patient-population
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
FDA Advisory Committee Recommends Approval of Canagliflozin for Treatment of ...
https://www.jnj.com/media-center/press-releases/fda-advisory-committee-recommends-approval-of-canagliflozin-for-treatment-of-adults-with-type-2-diabetes
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Healthy Vision & Contact Lenses – New Educational Resource Offers Important A...
https://www.jnj.com/media-center/press-releases/healthy-vision-contact-lenses-new-educational-resource-offers-important-advice-on-safe-wear-and-care-of-contact-lenses
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
INVOKANA® (canagliflozin) Significantly Reduced Major Cardiovascular Events a...
https://www.jnj.com/media-center/press-releases/invokana-canagliflozin-significantly-reduced-major-cardiovascular-events-and-kidney-failure-in-patients-with-type-2-diabetes-and-chronic-kidney-disease-in-new-credence-analysis
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Our history
https://www.jnj.com/our-heritage
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Our history
https://www.jnj.com/our-heritage
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Our history
https://www.jnj.com/our-heritage
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
Janssen Launches Health Equity Campaign in Partnership with Award-Winning Rad...
https://www.jnj.com/media-center/press-releases/janssen-launches-health-equity-campaign-in-partnership-with-award-winning-radio-host-d-l-hughley-to-raise-awareness-about-multiple-myeloma-among-black-communities
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
|
The Story Behind Johnson & Johnson’s Historic Spring Cleaning Ads
https://www.jnj.com/our-heritage/the-story-behind-johnson-johnson-historic-spring-cleaning-ads
jnj.com
|
80 | 1,350 | 880 |
Nursing
https://nursing.jnj.com/
DOFOLLOW
|
Frequently Asked Questions
How many backlinks does nursing.jnj.com have?
The backlinks page for nursing.jnj.com shows all individual inbound links discovered in our crawl of the web. Each backlink represents a hyperlink on another website that points to a page on nursing.jnj.com. Use the filters to narrow results by dofollow/nofollow status, domain rating, or anchor text.
What is a backlink?
A backlink is a hyperlink on one website that points to a page on a different website. Backlinks are one of the most important ranking factors in search engine algorithms because they act as votes of confidence from other sites. The more high-quality backlinks a domain has, the more authority search engines assign to it.
Are the backlinks to nursing.jnj.com dofollow or nofollow?
Backlinks to nursing.jnj.com include both dofollow and nofollow links. Dofollow links pass link equity (ranking power) to the target site, while nofollow links include a rel="nofollow" attribute that tells search engines not to pass authority. Both types contribute to a natural backlink profile, but dofollow links carry more SEO weight. You can filter by link type using the rel filter above the table.
How often is backlink data updated?
Backlink data is updated monthly when our web crawler completes a new cycle. Our pipeline processes billions of web pages to discover new backlinks, track lost links, and update domain authority scores. The freshness of data depends on when our crawler last visited the referring pages.